Hainan Huluwa Pharmaceutical Group News

Announcement of Hainan Huluwa Pharmaceutical Group Co., Ltd. on holding the 2024 semi-annual results briefing

Aug 30 12:00 ET

Hainan Huluwa Pharmaceutical Group Co., Ltd. Investor Relations Activity Record Form

Aug 30 06:28 ET

Announcement of Resolutions of the Fourth Meeting of the Third Board of Supervisors of Hainan Huluwa Pharmaceutical Group Co., Ltd.

Aug 28 12:00 ET

Special report on the storage and actual use of funds raised in the 2024 semi-annual period of Hainan Huluwa Pharmaceutical Group Co., Ltd.

Aug 28 12:00 ET

Announcement of Resolutions of the Fourth Meeting of the Third Board of Directors of Hainan Huluwa Pharmaceutical Group Co., Ltd.

Aug 28 12:00 ET

Announcement of Hainan Huluwa Pharmaceutical Group Co., Ltd. on obtaining a drug registration certificate for inhaled acetylcysteine solution

Aug 27 12:00 ET

Hainan Huluwa Pharmaceutical Group Co., Ltd. Investor Relations Activity Record Form

Aug 14 04:58 ET

Announcement on obtaining the approval notice for drug clinical trials by Hainan Huluwa Pharmaceutical Group Co., Ltd.

Jul 23 12:00 ET

Announcement of Hainan Huluwa Pharmaceutical Group Co., Ltd. regarding obtaining the registration certificate of propofol and tenofovir tablets.

Jul 17 12:00 ET

Announcement from Hainan Huluwa Pharmaceutical Group Co., Ltd. regarding the generic drug consistency evaluation of omeprazole enteric-coated capsules.

Jul 12 12:00 ET

Announcement of Hainan Huluwa Pharmaceutical Group Co., Ltd. Obtaining the Registration Certificate for Montelukast Sodium Chewable Tablets

Jun 18 12:00 ET

Announcement of Hainan Huluwa Pharmaceutical Group Co., Ltd. receiving notification of pharmaceutical GMP compliance inspection report.

Jun 4 12:00 ET

Announcement of Hainan Huluwa Pharmaceutical Group Co., Ltd. receiving government subsidies

May 30 12:00 ET

Announcement of Hainan Huluwa Pharmaceutical Group Co., Ltd. receiving government subsidies

May 27 12:00 ET

Announcement of Hainan Huluwa Pharmaceutical Group Co., Ltd. on holding a performance briefing for the first quarter of 2023 and 2024

May 7 12:00 ET

Announcement of Hainan Huluwa Pharmaceutical Group Co., Ltd. on participating in the “2023 Hainan Listed Companies Performance Briefing Conference and Investor Group Reception Day”

May 7 12:00 ET

Announcement of Hainan Huluwa Pharmaceutical Group Co., Ltd. on obtaining a drug registration certificate

Apr 30 12:00 ET

Ernst & Young Huaming (2024) reviews Audit Report No. 70060529_X01

Apr 26 12:00 ET

Hainan Huluwa Pharmaceutical Group Co., Ltd. 2023 Independent Director Debriefing Report (Liu Qiuyun)

Apr 26 12:00 ET

Hainan Huluwa Pharmaceutical Group Co., Ltd. 2023 Environmental, Social and Corporate Governance (ESG) Report

Apr 26 12:00 ET